Skip to content

13F-HR filed by Medicxi Ventures Management (Jersey) Ltd

Medicxi Ventures Management (Jersey) Ltd filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-03, with 7 holding rows worth $240,803,000.

Accession
0000950123-22-007682
Filed
2022-08-03
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 7 entries on the cover page, a total value of $240,803,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $240,803,000 with VALUE read as thousands by filing date, 13F file number 028-19833. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

Other managers

  • included managerFrancesco De Rubertis

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS19,963,157$97,221,000thousands by filing date
AURA BIOSCIENCES INC05153U107COMMON STOCK3,039,892$43,075,000thousands by filing date
VAXCYTE INC COM92243G108Stock1,887,478$41,071,000thousands by filing date
MERUS N VN5749R100COM1,600,000$36,224,000thousands by filing date
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK2,450,679$20,684,000thousands by filing date
ObsEva SAH5861P103COM1,570,000$2,528,000thousands by filing date
CHECKMATE PHARMACEUTICALS IN162818108COM0$0thousands by filing dateValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-007682this filing2022-08-03acceptance time not in the bulk data set
13F-HR/A 0000950123-22-007699 base2022-08-03acceptance time not in the bulk data set